DLL4 and urinary bladder cancer: Using established cell lines with luminal and basal/squamous signatures, transient knockdown by siRNA, CRISPR knockout, and in silico models, we examine the influence of heterogeneity of NOTCH1-DLL4 signaling on bladder cancer invasion.